FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313532458> ?p ?o ?g. }

• W4313532458 abstract "<h3>Background</h3> The Type 1 & 2 SLE Model was developed to better explain the signs, symptoms, and management goals of systemic lupus erythematosus (SLE) to patients. We assembled tools to discuss the Type 1 & 2 SLE Model, collectively called SLE@Duke, including patient-reported outcome (PRO) measures, physician global assessments (PGAs) for Type 1 and 2 SLE activity, and a patient handout. In this pilot study, we aimed to implement SLE@Duke into rheumatology care with the goal of increasing the frequency of discussion of the Type 1 & 2 SLE Model. <h3>Methods</h3> We conducted a 4-week study in Duke Rheumatology Clinics. Providers received training on SLE@Duke that reviewed each of the tools, summarized approaches to treating Type 2 SLE, and scored case examples of PGAs. During the intervention period, patients with SLE received a questionnaire at check-in that included the Systemic Lupus Activity Questionnaire and the American College of Rheumatology Fibromyalgia Severity Score. After each visit, patients completed an anonymous satisfaction survey. Providers completed baseline and follow-up surveys on their satisfaction with care and acceptability, appropriateness, and feasibility of SLE@Duke. Clinic notes of patients seen during the intervention period and 4-weeks prior to the intervention were reviewed. Providers were invited to participate in interviews about their experience after the intervention period. <h3>Results</h3> Sixteen of 25 eligible providers participated (3 APPs, 8 faculty, 5 fellows); 67 patients with SLE were seen (36 pre-intervention and 31 intervention). At follow-up, provider surveys showed high scores for acceptability (4.0/5), appropriateness (4.15/5), and feasibility (4.2/5) of SLE@Duke (table 1). All providers agreed or completely agreed the intervention seemed possible; there was an increase in the proportion who felt the intervention was easy to use (50% to 83%). Type 1 & Type 2 PGAs were documented in 87% of notes. The discussion of Type 2 SLE symptoms increased from 44% to 74% of patients (p=0.02). Importantly, there was not an increase in the duration of clinic visits during the intervention period (table 2). Among 49 patients who completed surveys, satisfaction with care remained high (table 3). In interviews, most providers found SLE@Duke helpful to guide conversations and validate patients’ feelings. Suggestions to improve SLE@Duke included a shortened PRO measure, more training on scoring PGAs, a referral network for Type 2 SLE symptom management, and more resources for patients and providers about Type 1 & 2 SLE. <h3>Conclusion</h3> Through SLE@Duke, our general rheumatologists increased their discussion of Type 2 SLE symptoms without significantly increasing the duration of clinic visits. All patients remained highly satisfied with their care. Future work will take this intervention to other rheumatology clinics to determine its impact on patient outcomes. <h3>Trial Registration</h3> NCT05426902 <h3>Lay Summary</h3> In this pilot study, we assembled tools to discuss the Type 1 & 2 SLE Model, collectively called SLE@Duke. By implementing the Type 1 & 2 SLE Model, our general rheumatologists increased their discussion of Type 2 SLE symptoms without significantly increasing the duration of clinic visits. All patients remained highly satisfied with their care." @default.
• W4313532458 created "2023-01-06" @default.
• W4313532458 creator A5002726318 @default.
• W4313532458 creator A5015062757 @default.
• W4313532458 creator A5025043247 @default.
• W4313532458 creator A5025998709 @default.
• W4313532458 creator A5030355164 @default.
• W4313532458 creator A5050605226 @default.
• W4313532458 creator A5056570442 @default.
• W4313532458 creator A5073949031 @default.
• W4313532458 creator A5085160815 @default.
• W4313532458 date "2022-12-01" @default.
• W4313532458 modified "2023-10-07" @default.
• W4313532458 title "615 A pilot study to implement the Type 1 & 2 SLE Model into clinical care" @default.
• W4313532458 doi "https://doi.org/10.1136/lupus-2022-lupus21century.36" @default.
• W4313532458 hasPublicationYear "2022" @default.
• W4313532458 type Work @default.
• W4313532458 citedByCount "0" @default.
• W4313532458 crossrefType "proceedings-article" @default.
• W4313532458 hasAuthorship W4313532458A5002726318 @default.
• W4313532458 hasAuthorship W4313532458A5015062757 @default.
• W4313532458 hasAuthorship W4313532458A5025043247 @default.
• W4313532458 hasAuthorship W4313532458A5025998709 @default.
• W4313532458 hasAuthorship W4313532458A5030355164 @default.
• W4313532458 hasAuthorship W4313532458A5050605226 @default.
• W4313532458 hasAuthorship W4313532458A5056570442 @default.
• W4313532458 hasAuthorship W4313532458A5073949031 @default.
• W4313532458 hasAuthorship W4313532458A5085160815 @default.
• W4313532458 hasBestOaLocation W43135324581 @default.
• W4313532458 hasConcept C126322002 @default.
• W4313532458 hasConcept C141071460 @default.
• W4313532458 hasConcept C159110408 @default.
• W4313532458 hasConcept C1862650 @default.
• W4313532458 hasConcept C198451711 @default.
• W4313532458 hasConcept C2775944032 @default.
• W4313532458 hasConcept C2777831278 @default.
• W4313532458 hasConcept C2780665704 @default.
• W4313532458 hasConcept C512399662 @default.
• W4313532458 hasConcept C71924100 @default.
• W4313532458 hasConceptScore W4313532458C126322002 @default.
• W4313532458 hasConceptScore W4313532458C141071460 @default.
• W4313532458 hasConceptScore W4313532458C159110408 @default.
• W4313532458 hasConceptScore W4313532458C1862650 @default.
• W4313532458 hasConceptScore W4313532458C198451711 @default.
• W4313532458 hasConceptScore W4313532458C2775944032 @default.
• W4313532458 hasConceptScore W4313532458C2777831278 @default.
• W4313532458 hasConceptScore W4313532458C2780665704 @default.
• W4313532458 hasConceptScore W4313532458C512399662 @default.
• W4313532458 hasConceptScore W4313532458C71924100 @default.
• W4313532458 hasLocation W43135324581 @default.
• W4313532458 hasLocation W43135324582 @default.
• W4313532458 hasOpenAccess W4313532458 @default.
• W4313532458 hasPrimaryLocation W43135324581 @default.
• W4313532458 hasRelatedWork W2043627819 @default.
• W4313532458 hasRelatedWork W2093754323 @default.
• W4313532458 hasRelatedWork W2151635818 @default.
• W4313532458 hasRelatedWork W2469458214 @default.
• W4313532458 hasRelatedWork W2622204852 @default.
• W4313532458 hasRelatedWork W2911926705 @default.
• W4313532458 hasRelatedWork W2973166306 @default.
• W4313532458 hasRelatedWork W3087107815 @default.
• W4313532458 hasRelatedWork W4292526722 @default.
• W4313532458 hasRelatedWork W4379768956 @default.
• W4313532458 isParatext "false" @default.
• W4313532458 isRetracted "false" @default.
• W4313532458 workType "article" @default.